Acesion Pharma ("Acesion" or "the Company"), a biotech company pioneering treatments for atrial fibrillation ("AF"), the most common cardiac arrhythmia, today announces enrolment of the first patients ...
DuRoBo, a company focused on innovative ePaper and AI technology, announced that it will exhibit at CES 2026, where attendees can experience Krono, the company's smart ePaper focus hub. DuRoBo will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback